A new Project IGI is officially in the early stages of development. Project IGI, sometimes referred to as Project IGI: I'm Going In, is a classic, quasi-open world stealth action series. Norwegian ...
NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 /PRNewswire/ -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (ABBV) today ...
AbbVie has acquired global rights to the lead pipeline asset of Ichnos Glenmark Innovation (IGI), the cancer and autoimmune disease candidate ISB 2001, now in development against multiple myeloma, ...
(RTTNews) - AbbVie (ABBV) and IGI Therapeutics SA, a unit of Ichnos Glenmark Innovation, Inc. (IGI), Thursday announced partnership to develop IGI's ISB 2001 for oncology and autoimmune diseases. As ...
AbbVie has entered into a $1 billion licensing agreement with IGI Therapeutics SA for IGI's lead investigational drug for oncology and autoimmune diseases. The deal will give AbbVie exclusive rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results